Novel drug combination nanoparticles exhibit enhanced plasma exposure and dose-responsive effects on eliminating breast cancer lung metastasis.

Early diagnosis along with new drugs targeted to cancer receptors and immunocheckpoints have improved breast cancer survival. However, full remission remains elusive for metastatic breast cancer due to dose-limiting toxicities of heavily used, highly potent drug combinations such as gemcitabine and...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Qingxin Mu, Jesse Yu, James I Griffin, Yan Wu, Linxi Zhu, Lisa A McConnachie, Rodney J Y Ho
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2020
Materias:
R
Q
Acceso en línea:https://doaj.org/article/cb89d7d76ccd4535a410f364e5bbf9bc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares